Save
Email
Print
Share
RSSBrowse News Stories
21 to 30 of 112 stories
view headlines only
-
Promising Discovery in Pursuit of Effective Lymphoma Treatments
May 16, 2012 — Researchers have identified a target for slowing the progression of multiple myeloma by using currently available ... > full story -
New Maintenance Therapy for Multiple Myeloma Looks Promising, Study Suggests
May 11, 2012 — Multiple myeloma is a form of cancer where the plasma cells in the bone marrow grow out of control, causing damage to bones as well as predisposing patients to anemia, infection and kidney failure. ... > full story -
Leukemia
Diseases and Conditions
Chronic Illness
Multiple Myeloma
Multiple Sclerosis Research
Wounds and Healing
Lenalidomide Shows Significant Benefit for Myeloma Patients, Phase III Study Suggests
May 9, 2012 — Medical researchers report significant time-to-progression benefit as well as survival benefit for patients who took maintenance doses of lenalidomide following stem-cell ... > full story -
Peptide 'Cocktail' Elicits Immune Response to Multiple Myeloma
December 12, 2011 — Scientists have created a "cocktail" of immune-stimulating peptides they believe could provoke the body's defenses to attack multiple myeloma in its early "smoldering" phase and slow or prevent the ... > full story -
Study May Help Physicians Determine How Patients Will Respond to Immunomodulator Therapy for Multiple Myeloma
December 11, 2011 — Research on the same protein that was a primary mediator of the birth defects caused by thalidomide now holds hope in the battle against multiple myeloma, new research ... > full story -
Multiple Myeloma
Leukemia
Cancer
Multiple Sclerosis Research
Personalized Medicine
Diseases and Conditions
Multicenter 1000-Patient Trial Initiated to Accelerate Development of Personalized Treatments for Multiple Myeloma
September 20, 2011 — Clinical sites are beginning to enroll patients in a landmark study designed to uncover the molecular segments and variations of multiple ... > full story -
Researchers Use New Tool to Counter Multiple Myeloma Drug Resistance
September 9, 2011 — Researchers are pioneering promising research utilizing a monitoring technology that could provide a better understanding of acquired drug resistance and assist in clinical decision-making for ... > full story -
Novel Approach Scores First Success Against Elusive Cancer Gene
September 9, 2011 — Researchers successfully disrupted the function of the gene MYC by tampering with the gene's "on" switch and growth signals in multiple myeloma cells, offering promising strategy for treating myeloma ... > full story -
Study Urges Caution With Lenalidomide Dosage; Drug Found to Interact With P-Glycoprotein
August 8, 2011 — An early phase myeloma trial has unexpectedly revealed that the drug lenalidomide interacts with another protein in cells that affect its dose level in the body. The drug is under study in more than ... > full story -
First Look at the Full Multiple Myeloma Genome Reveals New Insights, Discoveries
March 23, 2011 — Scientists have unveiled the most comprehensive picture to date of the full genetic blueprint of multiple myeloma, a form of blood ... > full story
Search ScienceDaily
Number of stories in archives: 140,690
more 
